The Association highlighted that infection rates have dropped from five percent to one percent, with over 40 million Iranians having received the hepatitis vaccine. In fact, many cities in Iran currently report no cases of hepatitis infection. This achievement is attributed to improved access to effective medications for treating hepatitis B and C, resulting in the lowest infection levels in the country.